GERD (acid reflux) decisions — 2025

The Board denied service connection for erectile dysfunction and GERD as there is no evidence of current disabilities at any time during the pendency of the claim or recent to the filing of the claim.

The Board granted service connection for gastroesophageal reflux disease, unspecified headaches, and obstructive sleep apnea as directly related to the Veteran's military service.

The Board granted an initial rating of 70 percent for the Veteran's service-connected depressive disorder due to another medical condition with depressive features and generalized anxiety disorder, denied a higher rating for his migraine including migraine variants, and denied ratings for other conditions.

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected schizoaffective disorder, bipolar type, including other residuals of traumatic brain injury.

The Board denied service connection for a prostate condition, GERD, PTSD, erectile dysfunction, arthritis (trigger finger), and an initial disability rating in excess of 10 percent for tinnitus.

The Board granted a rating of 30 percent for gastroesophageal reflux disease with chronic gastritis, finding that the Veteran's symptoms were productive of considerable impairment of health.

The Board denied the veteran's claims for service connection, higher ratings, and earlier effective dates, as well as dismissed his claim for a TDIU.

The Board granted a 30 percent rating for the Veteran's gastroesophageal reflux disease (GERD) from October 22, 2021.

The Board denied the veteran's claims for service connection for PTSD, COPD, a gastrointestinal disability, and migraines due to lack of evidence supporting a link between these conditions and her military service.

The Board denied service connection for GERD, a heart condition, hypertension, a kidney condition, and obstructive sleep apnea as there is no evidence of current disabilities related to these conditions or that they are etiologically linked to the Veteran's military service.

The Board granted a 30 percent rating for the Veteran's right upper extremity nerve damage and denied an increased rating for left upper extremity nerve damage. Other issues were remanded.

The Board granted service connection for cirrhosis, hepatitis C, hepatocellular carcinoma, gastroesophageal reflux disease (GERD), gastritis, Barrett's esophagus, and obstructive sleep apnea but dismissed the claim for an acquired psychiatric disability.

The Board granted a disability rating of 50 percent for obstructive sleep apnea and asthma from September 25, 2017 to July 22, 2018, but denied a higher rating. It also granted ratings of 60 percent for GERD and 30 percent for allergic rhinitis during the entire appeal period.

The Board dismissed the appeal for service connection for anxiety disorder and denied service connection for hearing loss. The claims for service connection for GERD, right ankle limitations, and sinusitis were remanded for further development.

The Board denied an initial rating in excess of 10 percent for GERD and remanded the claims for service connection for chronic fatigue syndrome, a back disability, and sinusitis.

The Board granted a 10 percent evaluation for the Veteran's GERD, finding that his condition is productive of daily medications to control dysphagia and is otherwise asymptomatic.

The Board denied the claims for an initial compensable rating for left ear sensorineural hearing loss, service connection for a right ear hearing loss disability, and a left eye disorder. However, it granted service connection for a back disability and radiculopathy of both lower extremities as secondary to the back disability.

The Board remands the claims for service connection for maxillary and ethmoid sinusitis, headaches, and an initial rating in excess of 10 percent for GERD due to insufficient medical evidence.

The Board granted service connection for erectile dysfunction and denied service connection for left foot tendonitis. The Veteran's gastroesophageal reflux disease and bilateral pes planus with plantar fasciitis were rated in excess of 10 percent and 50 percent, respectively.

The Board granted the restoration of a 30 percent evaluation for dermatophytosis, onychomycosis, and calluses of the feet due to an improper reduction. The claim for service connection for GERD was remanded for further development.